Iovance Biotherapeutics, Inc.
IOVA
Revenue
31.11M
▲30.39M▲4250.49%
3 Months ChangeAssets
964.32M
▲94.49M▲10.86%
3 Months ChangeLiabilities
195.78M
▲5.98M▲3.15%
3 Months ChangeFree Cash Flow
-126.45M
▼-20.97M▼-19.88%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 8-K
ID: 0001104659-24-087876
2024-08-08
Form 10-Q
ID: 0001558370-24-011641
2024-08-08
Form 8-K
ID: 0001104659-24-087259
2024-06-28
Form 8-K
ID: 0001104659-24-075997
2024-06-11
Form 8-K
ID: 0001104659-24-070470
2024-06-03
Form 8-K
ID: 0001104659-24-067485
2024-05-24
Form 8-K
ID: 0001104659-24-064825
2024-05-09
Form 10-Q
ID: 0001558370-24-007646
2024-05-09
Form 8-K
ID: 0001104659-24-059322
2024-04-03
Form 8-K
ID: 0001104659-24-043158